Managing the Care of Ovarian Cancer With Poly(ADP-Ribose) Polymerase Inhibitors: A Managed Care Approach

This activity is delivered in partnership with Academy of Managed Care Pharmacy and Medscape.


Course Description: 

The goal of this 30-minute video activity is to educate managed care pharmacists, clinical pharmacists in different practice settings, and physicians about the clinical utility of PARP inhibitors in advanced ovarian cancer (OC); review considerations important in delivering evidence-based, cost-effective therapy in OC; and summarize the role of managed care pharmacists in coordinating care with the interprofessional team to achieve optimal patient outcomes.

Follow the link below!

https://www.medscape.org/viewarticle/984263?ecd=par_amcp_distr_mscpedu